In this podcast, Julie Ann Justo, PharmD, MS, FIDSA, BCPS, discusses treatment of carbapenem-resistant Enterobacterales (CRE) infections, including:
Burden of CRE infections in the United States
Mechanisms of resistance
Changing epidemiology
Use of rapid diagnostic tests
IDSA guidance recommendations, including supporting data
Approach to designing treatment regimens, including weighing patient- and infection-related factors
Faculty:
Julie Ann Justo, PharmD, MS, FIDSA, BCPS Clinical Pharmacist Lead – Infectious Diseases Inpatient Pharmacy Dartmouth Hitchcock Medical Center Lebanon, New Hampshire
Podden och tillhörande omslagsbild på den här sidan tillhör
ProCE. Innehållet i podden är skapat av ProCE och inte av,
eller tillsammans med, Poddtoppen.